Pharmaceutical manufacturer the Adcock Ingram Group posted headline earnings from continuing operations of R709.4-million for the financial year ended June 30. This was an increase on the headline earnings of R701-million posted for the 2019 financial year.
from Engineering News | Home https://ift.tt/3jgaU1M
